November 01, 2014 5:06 AM ET

Life Sciences Tools and Services

Company Overview of Promega Corporation

Company Overview

Promega Corporation provides solutions and technical support services for the life sciences industry. It manufactures reagents and instrumentations; and offers products in the areas of genomics, protein analysis and expression, cellular analysis, drug discovery, and genetic identity. The company also provides DNA and RNA quantitation, DNA extraction, and sample ID and mixed sample detection products; and bio chemicals and laboratory ware, such as buffers and reagents, nucleic acids, and nucleic acids purification accessories. In addition, it offers products and services in the areas of biologics, cell health and metabolism, cell signaling, cloning and DNA markers, DNA and RNA purification, d...

2800 Woods Hollow Road

Madison, WI 53711

United States

Founded in 1978





Key Executives for Promega Corporation

Age: 66
Vice President of Finance and Chief Financial Officer
Age: 47
Chief Technical Officer and Vice President
Senior Executive Officer
Age: 62
Vice President of Global Sales
Compensation as of Fiscal Year 2014.

Promega Corporation Key Developments

Promega Corp., Expand with New $30 Million Plant

Promega Corp. announced another manufacturing building at 5455 Nobel Drive, a short jog south in the Fitchburg Technology Campus. The 100,000-square-foot building, more on the conventional side, will be used to package and ship the enzymes, proteins and other biological products made at its BioPharmaceutical Technology Center (BTC), 5445 E. Cheryl Pkwy. The BTC produces a wide variety of tools used worldwide for scientific research, cell analysis and DNA tests for human identification.

Promega Corporation to Break Ground for New Processing and Manufacturing Facility

Promega Corporation announced that the company will break ground for a new processing and manufacturing facility near its primary campus in Fitchburg on July 10, 2014. The facility will allow for efficiency improvements for processing, packaging, staging and shipping products. The new processing and manufacturing facility will initially work with processing, packaging, staging and shipping. In addition, the floor plan will allow for potential expansion of manufacturing and logistics operations to meet growing business needs in the future. Most Promega products are temperature sensitive and require specialized temperature controlled facilities and equipment to hold the inventory stock for daily processing. Inventory will be pulled from designated locations, processed, packed and shipped out to customers worldwide. Raw materials and other inventory needed to process products will be received and housed at the facility, and used on-site or distributed to other Promega facilities as needed.

Promega Launches New Mass Spectrometry Reagents

Promega Corporation has introduced new mass spectrometry reagents, IdeS Protease, and human and yeast protein extracts for mass spectrometry applications. The IdeS Protease enables fast, easy, high performance digestion of immunoglobulin, while the Human and Yeast Protein Extracts provide a test material for optimizing mass spec sample preparation. The new products add to the company's existing range of proteases and services to improve mass spec. sample prep. workflows. IdeS Protease is a recombinant, engineered version of the immunoglobulin-degrading enzyme from Streptococcus pyogenes. It is a highly specific protease that slices Immunoglobulin G (IgG) at a single, targeted site, offering 100% digestion in 30 minutes with no optimization. IdeS can be used to characterize therapeutic antibody candidates using LC/MS, and contains a histidine tag for easy removal. The versatile Promega IdeS enzyme cuts IgGs from a range of species, as well as Fc-fusion proteins. The new yeast and human protein extracts are designed specifically for mass spectrometry applications. Available in either predigested, cleaned form for immediate use in LC/MS analysis or intact, undigested form to provide a test material for optimizing mass spec protein sample preparation, the extracts provide clean, consistent, quantified, model system samples for LC/MS method development and instrument monitoring. The yeast extracts are beneficial for users who prefer working with a relatively compact and well-studied proteome, whereas the human extract, with large dynamic range, provides the opportunity to work with complex proteomes. The new products are: MS Compatible Yeast Protein Extract, Digest; MS Compatible Human Protein Extract, Digest; MS Compatible Yeast Protein Extract, Intact; and MS Compatible Human Protein Extract, Intact.

Similar Private Companies By Industry

Company Name Region
Prospero Biosciences, LLC United States
SciLog, Inc. United States
Interface Associates, Inc. United States
Primera Analytical Solutions Corporation United States
Harlan Laboratories, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Promega Corporation, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at